EIDPARRY
Large CapEID Parry India Limited
Consumer
EID Parry is a diversified Indian company with interests in Sugar & Biofuels, Nutraceuticals, and Consumer Products. It operates sugar plants and distilleries across South Indian states, focusing on operational efficiency and portfolio reshaping for long-term value creation.
One read, four checks
75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.
Weak fundamentals, management trust is acceptable, price trend argues for patience, and recent execution is consistent.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
low confidence · 0/0 claims checked
Timing lens: price trend and sector relative strength.
Rolling lens: recent quarterly delivery, not the latest single-result score.
Quarter ended 31 Mar 2026
Bad · 0/100PAT -153% YoY · margin compression · Rev +16% YoY
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹7,882 Cr | +15.7% | -23.6% |
| EBITDA | ₹611 Cr | +19.1% | -26.8% |
| Operating margin | 8.0% | +0 bps | +0 bps |
| PAT | ₹-287 Cr | -153.3% | -165.7% |
| PAT margin | -3.6% | -1155 bps | -788 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Where growth can come from, and what can break the case
FY26 results show a challenging year with consolidated revenue from operations at INR 7,055 Cr (down 6.2% YoY) and a PBT loss of INR 216 Cr (vs loss of INR 74 Cr YoY), impacted by significant exceptional items and underperforming segments.
Management acknowledges a challenging year, undertaking portfolio reshaping and exiting a business. Consolidated losses increased significantly due to exceptional items and underperforming segments like Consumer Products and Distillery. A strategic reset is underway, but execution and turnaround in loss-making segments are critical.
Consumer Products Portfolio Premiumization
Transition to value-added, brand-led portfolio (jaggery & other sweeteners) and de-focus from lower-contribution bulk categories like rice and pulses.
Nutraceuticals Market Expansion & New Products
Regaining share in key EU and US markets, expanding in emerging markets, and progressing entry into new product segments around Derma/Hair Health.
Sugar & Biofuels Revenue Maximization
Maximising revenue streams across sugar, co-generation, and distillery segments through operational efficiencies and cost reduction.
New Jaggery Facility
Investment in a new state-of-the-art Jaggery facility in Karnataka is underway, expected to be commissioned by the end of FY27 Q3.
Domestic Sugar Pricing Outlook
Projected lower cane output and closing stock in SY26E are expected to lead to a Neutral/Positive pricing outlook.
Branded Sugar Market Growth
Branded white sugar market in India expected to grow at ~8-9% p.a. to ~INR 8,000 Cr by 2030, driven by increased branded penetration.
Niche Sweeteners Adoption
Non-sugar/Jaggery-based sweeteners constitute ~2% of the market but are driving growth at ~30%.
Sugar & Biofuels Cost Pressures
Increasing cost pressures, unfavorable economics in the Ethanol segment, and a dull market for Sugar exports.
Distillery Segment Profitability
Loss due to increase in feed stock cost and reduction in selling price.
Consumer Products Performance
Increase in loss due to lower sales volume, higher input costs, and channel corrections.
Geopolitical and Policy Uncertainty
Management highlights the need to navigate an uncertain geopolitical and policy environment.
Portfolio Realignment Challenges
Decision to exit Parry Sugars & Refinery business due to operational challenges, structural unviability, and high debt.
Underperforming Bulk Categories
Initial foray into lower-contribution bulk categories such as rice and pulses did not meet expectations.
What management said, and what results must prove
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
YoY comparison is essential for understanding full-year performance and the impact of seasonality in the sugar business. QoQ provides insight into recent momentum and the immediate effects of strategic resets in Consumer Products and Nutraceuticals.
Sugar Revenue (FY26)
INR 5,366 Cr (vs INR 5,781 Cr FY25)
Sugar PBT (FY26)
INR 54 Cr (vs loss of INR 115 Cr FY25)
Distillery PBT (FY26)
Loss of INR 14 Cr (vs profit of INR 37 Cr FY25)
Nutraceuticals PBT (FY26)
INR 19 Cr (vs INR 3 Cr FY25)
FY27 Priorities: 'Disciplined Renewal'
Focus on strengthening the core, driving margin improvement, stronger working capital/cash flow management, and accelerating digital/AI-led transformation.
Consumer Products Strategic Reset
FY25-26 marked a year of strategic reset and sharper prioritization, recalibrating away from lower-contribution bulk categories towards value-added segments.
Numbers and claims to verify in the next filings
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Sugar Segment PBT | INR 54 Cr (FY26) | Sustained profitability improvement and positive impact from operational efficiencies. |
| Distillery Segment PBT | Loss of INR 14 Cr (FY26) | Reversal of losses, indicating better management of feedstock costs and selling prices. |
| Consumer Products PBT | Loss of INR 109 Cr (FY26) | Margin expansion and improved profitability from portfolio premiumization and channel strategies. |
| New Jaggery Facility Commissioning | Expected by end of FY27 Q3 | Timely completion and successful ramp-up of the new facility in Karnataka. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trend score and candlestick chart
42NeutralSMA20 -14.7% / mo · near 52W low
Technical chart
EIDPARRYdaily · 3Y-27.6%Technical trend read
Bearish setupTrend is weak — long-term trend unclear. RSI 36.
- SMA20 falling (~10.7% over last month) — short-term momentum negative.
- RSI(14) at 36 — sideways, no extreme reading.
- MACD below signal, histogram expanding negatively — bearish momentum building.
- Within 5% of 52-week low — testing support.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Valuation, score drivers, trust methodology, financials, and peers
Use these sections after reviewing the decision summary, latest result, thesis, management accountability, and technical timing above.
Fundamental score breakdown
WATCHLISTWhy this score?
Top U-Score contributors and drags from the latest stored fundamentals.
Positive drivers
- Piotroski is strong at 8/9.
- Balance sheet contributes 8/15 to the score.
- Cash flow contributes 4/10 to the score.
Main drags
- Quality is weaker at 1/20; verify the latest quarterly trend.
- Growth is weaker at 9/25; verify the latest quarterly trend.
- Valuation is weaker at 11/30; verify the latest quarterly trend.
Cyclical valuation: normalized earnings, not just trailing PE
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Score history
12 stored score snapshots. Latest stored move: +1 points.
Factor attribution
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Healthy Trust: Claim history is still being built. It ranks around the 73rd percentile of the scored universe and 73rd percentile within Consumer. No major sub-score weakness stands out.
Healthy Trust Lite: Promoter pledge is zero. Key concern: 1 of the latest 4 quarters had PAT decline worse than 25% YoY.
Generally investable credibility. Look for weak sub-scores before increasing position size.
overall median 67 · Consumer: 73rd pctile, median 67 · Large: 50th pctile, median 74
91 documents indexed, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Healthy Trust · low confidenceRead Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust positives
- ▸Promoter pledge is zero.
- ▸4 years of positive FCF.
- ▸4/4 latest quarters had positive YoY revenue growth.
- ▸3/4 latest quarters had positive YoY PAT growth.
Trust risks
- ▸1 of the latest 4 quarters had PAT decline worse than 25% YoY.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Intrinsic value
Fundamentals
Valuation
- P/E
- 18.50
- P/B
- 1.46
- EV/EBITDA
- 3.88
- Market Cap
- 12836.00Cr
Profitability
- ROE
- 8.30%
- ROCE
- 17.80%
- ROA
- 4.72%
- Dividend Y
- —
Growth (CAGR)
- Revenue 5Y
- 16.00%
- EPS 5Y
- 8.00%
- Revenue 3Y
- 3.00%
- EPS 3Y
- -9.00%
Balance Sheet
- Debt/Equity
- 0.40
- Interest Coverage
- 7.60×
- Altman Z
- 2.61
- Book Value
- 493.00
Cash Flow
- FCF Yield
- —
- FCF Positive Y
- 4/5
- OCF
- 1542.00 Cr
- EPS TTM
- 32.02
Shareholding
- Promoter Hold
- 41.45%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 1%
Financial History
Updated 9/6/2026
Revenue
₹ CrNet Profit
₹ CrReturn on Equity
%Peers
Business-comparable peers in Consumer — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.